ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany · Delayed Price · Currency is EUR 55.50
0.00 (0.00%)
At close: Jul 23, 2025
ANI Pharmaceuticals Company Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians.
ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANI Pharmaceuticals, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Pharmaceutical Preparations |
| Employees | 897 |
| CEO | Nikhil Lalwani |
Contact Details
Address: 210 Main Street West Baudette, Delaware 56623 United States | |
| Phone | 218 634 3500 |
| Website | anipharmaceuticals.com |
Stock Details
| Ticker Symbol | BSFA |
| Exchange | Stuttgart Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nikhil Lalwani | Chief Executive Officer |
| Stephen Carey | Chief Financial Officer |